APA

Germing U., Hildebrandt B., Pfeilstöcker M., Nösslinger T., Valent P., Fonatsch C., Lübbert M., Haase D., Steidl C., Krieger O., Stauder R., Giagounidis A. A. N., Strupp C., Kündgen A., Mueller T., Haas R., Gattermann N. & Aul C. (20060119). Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). : Leukemia.

Chicago

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis A A N, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N and Aul C. 20060119. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). : Leukemia.

Harvard

Germing U., Hildebrandt B., Pfeilstöcker M., Nösslinger T., Valent P., Fonatsch C., Lübbert M., Haase D., Steidl C., Krieger O., Stauder R., Giagounidis A. A. N., Strupp C., Kündgen A., Mueller T., Haas R., Gattermann N. and Aul C. (20060119). Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). : Leukemia.

MLA

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis A A N, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N and Aul C. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). : Leukemia. 20060119.